September 11 — 13, 2025 JW Marriott Nashville

US Oncology Network Hereditary Genetics and Precision Medicine Conference 2025

Join Tempus and Ambry, a Tempus Company, to explore the early stages of our collaboration and the latest in AI-driven precision medicine. Learn about our innovative solutions, key differentiators, and see how we are advancing hereditary genetics and personalized care together.

Schedule a meeting with us

Breakout Session

Breakout Session

September 12, 2025

live session

Time
12:00pm - 1:00pm CDT

Location
Symphony Ballroom ABCD

Presenter
Steven M. Lipkin MD PhD,
CMO (Ambry)

Dr. Jyoti Patel, Vice President, Clinical Solutions (Tempus)

Tempus & Ambry Genetics: Advancing Hereditary Cancer and Precision Medicine Testing Together

Join Dr. Jyoti Patel (Tempus) and Dr. Steven Lipkin (Ambry Genetics) as they explore how Tempus’s AI-driven platform and Ambry’s hereditary cancer expertise are advancing precision medicine. The session will highlight how their combined somatic and germline testing capabilities offer a more comprehensive view of each patient's cancer and the expanded testing access throughout their journey.

Add to calendar

Schedule a meeting with us

We'll be in touch shortly.